Counterfeit drugs have become an increasing global threat over the last few decades. More and more regulatory authorities, including those of Argentina, Brazil, India, South Korea, Saudi Arabia, and Turkey, have adopted or will adopt requirements for the use of globally unique drug identifiers and serialization in order to protect the supply chain. These new…